Literature DB >> 25577251

Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population.

Huihui Li1, Hongchao Zhen, Lei Han, Bo Yan, Jing Yu, Shengtao Zhu, Bangwei Cao.   

Abstract

The correlation between TBX21 gene (T-box transcription factor protein 21; T-bet), which was a pivotal transcriptional regulation gene for Th1/Th2 polarization, and the development risk of esophagus squamous cell carcinoma (ESCC) was assessed in a high-risk Chinese population. A total of 302 ESCC cases and 311 normal controls coming from the highest incidence area of China were enrolled in this study. Three polymorphisms at -1499, -1514, and -1993 located in the TBX21 promoter were identified by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Logistic regression was used to determine whether the inherited variations of the TBX21 gene would associate with the risk and the clinicopathological characteristics of ESCC. Among the ESCC patients, an association between the TBX21 -1514T/C or -1993T/C polymorphisms and the lymph node or distant metastasis was found (odds ratios (ORs) were 9.46 and 4.35, respectively, all P < 0.01). By the log-additive model analysis, the results exhibited that three haplotypes, ACC, ACT, and ATC, were significantly related to the development risk of ESCC (OR = 11.81, 3.44, 2.37, respectively, all P < 0.05). TBX21 gene -1514 and -1993 polymorphisms might be counted as the influential factors for lymph node and distant metastasis to ESCC. Especially, the ACC, ACT, and ATC haplotypes derived from the TBX21 gene would increase the susceptibility to ESCC in the high-risk Chinese population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25577251     DOI: 10.1007/s13277-015-3042-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

1.  Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells.

Authors:  Nikhil S Joshi; Weiguo Cui; Claudia X Dominguez; Jonathan H Chen; Timothy W Hand; Susan M Kaech
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

2.  A common promoter variant of TBX21 is associated with allele specific binding to Yin-Yang 1 and reduced gene expression.

Authors:  J-R Li; J-G Li; G-H Deng; W-L Zhao; Y-J Dan; Y-M Wang; S Chen
Journal:  Scand J Immunol       Date:  2011-05       Impact factor: 3.487

3.  Intramucosal variant of nasal natural killer (NK)/T cell lymphoma has a better survival than does invasive variant: implication on loss of E26 transformation-specific sequence 1 (ETS-1) and T-box expressed in T cells (T-bet) with invasion.

Authors:  Ting-Chu Lin; Shee-Uan Chen; Ya-Fang Chen; Yeun-Chung Chang; Chung-Wu Lin
Journal:  Histopathology       Date:  2012-01       Impact factor: 5.087

4.  Association analysis of hepatitis virus B infection with haplotypes of the TBX21 gene promoter region in the Chinese population.

Authors:  Bangwei Cao; Hongli Yang; Howard Ding; Suxia Qi; Lei Gao; Hong Cui; Yue Dai; Changqing Xu
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

5.  A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer.

Authors:  S Reppert; I Boross; M Koslowski; Ö Türeci; S Koch; H A Lehr; S Finotto
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

6.  Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma.

Authors:  Mitsuteru Akahoshi; Kazuhiko Obara; Tomomitsu Hirota; Akira Matsuda; Koichi Hasegawa; Naomi Takahashi; Makiko Shimizu; Kazuko Nakashima; Lei Cheng; Satoru Doi; Hiroshi Fujiwara; Akihiko Miyatake; Kimie Fujita; Noritaka Higashi; Masami Taniguchi; Tadao Enomoto; Xiao-Quan Mao; Hitoshi Nakashima; Chaker N Adra; Yusuke Nakamura; Mayumi Tamari; Taro Shirakawa
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

7.  Differences in sensitivity to tumor-specific CTLs between primary and metastatic esophageal cancer cell lines derived from the same patient.

Authors:  Yoshinobu Ichiki; Takeshi Hanagiri; Mitsuhiro Takenoyama; Tetsuro Baba; Yoshika Nagata; Makiko Mizukami; Tetsuya So; Masakazu Sugaya; Manabu Yasuda; Hidetaka Uramoro; Kosei Yasumoto
Journal:  Surg Today       Date:  2012-01-12       Impact factor: 2.549

8.  IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine.

Authors:  Elodie Mohr; Adam F Cunningham; Kai-Michael Toellner; Saeeda Bobat; Ruth E Coughlan; Roger A Bird; Ian C M MacLennan; Karine Serre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

9.  Role of preoperative chemotherapy in squamous cell carcinoma of esophagus in kashmir, a cancer belt - a pilot study.

Authors:  Ghulam Nabi Lone; Ajaz Aziz Sheikh; Zahoor Ahmad Sheikh; Khalil M Baba; Mariya Amin Qurieshi; Gowhar Nazir Mufti; Zahoor Ahmed Naikoo; Abir Ahmed Syed; A G Ahangar; Reyaz A Lone; M L Sharma; Shyam Singh; M A Bhat; A M Dar
Journal:  Asian Pac J Cancer Prev       Date:  2011

Review 10.  Esophageal cancer: associated factors with special reference to the Kashmir Valley.

Authors:  Sabha Rasool; Bashir A Ganai; A Syed Sameer; Akbar Masood
Journal:  Tumori       Date:  2012 Mar-Apr
View more
  1 in total

1.  Investigation of GLUT1, HIF1α and TBX21 Gene Polymorphisms in Laryngeal Cancer.

Authors:  Cihan Uslu; Mustafa Tüz; Hasan Yasan; Erdoğan Okur
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.